MFDS
- Status: likely_approved
🇰🇷 Xenleta in South Korea
Xenleta (LEFAMULIN) regulatory status in South Korea.
Marketing authorisation
Xenleta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Xenleta approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Xenleta in South Korea?
Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.